Stock Rich List
#516 on the rich list of 14,452 insiders

Pablo G. Legorreta

CEO, Chairman of the Board at Royalty Pharma; Director at ProKidney. Based in New York, New York.

$448M
in disclosed stock, −$2.6M (−0.57%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
Rank
516th of 14,452
Companies held
2
Largest holding
RPRX, 74.7% of total
Latest SEC filing
Nov 4, 2026

What the $448M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
Royalty Pharma RPRX
Class A Ordinary Shares
Directly1,350,029$67.72$91.4M20.4%Form 4, Nov 4, 2026
ProKidney PROK
Class B Ordinary Shares
Indirectly (see filing footnote)84,283,430$1.06$89.3M19.9%Form 4, Jun 3, 2025
Royalty Pharma RPRX
Class A Ordinary Shares
Through Legorreta Children 2002 Trust1,040,410$67.72$70.5M15.7%Form 4, Nov 4, 2026
Royalty Pharma RPRX
Class A Ordinary Shares
Through GST-Exempt Legorreta 2012 Family Trust901,590$67.72$61.1M13.6%Form 4, Nov 4, 2026
Royalty Pharma RPRX
Class A Ordinary Shares
Through Legorreta 2023 SR Trust600,000$67.72$40.6M9.1%Form 4, Nov 4, 2026
Royalty Pharma RPRX
Class A Ordinary Shares
Through Legorreta Investments LLC460,139$67.72$31.2M7.0%Form 4, Nov 4, 2026
ProKidney PROK
Class A Ordinary Shares
Indirectly (see filing footnote)22,617,909$1.06$24.0M5.3%Form 4, Jun 3, 2025
Royalty Pharma RPRX
Class A Ordinary Shares
Through Tata MC 35 Ltd.292,190$67.72$19.8M4.4%Form 4, Nov 4, 2026
Royalty Pharma RPRX
Class A Ordinary Shares
Through IRRA123,310$67.72$8.4M1.9%Form 4, Nov 4, 2026
Royalty Pharma RPRX
Class A Ordinary Shares
Through SEP/IRA118,500$67.72$8.0M1.8%Form 4, Nov 4, 2026
Royalty Pharma RPRX
Class A Ordinary Shares
Through GST-Exempt Legorreta 2020 Family Trust41,306$67.72$2.8M0.6%Form 4, Nov 4, 2026
Royalty Pharma RPRX
Class A Ordinary Shares
Through Son10,000$67.72$677K0.2%Form 4, Nov 4, 2026
Royalty Pharma RPRX
Class A Ordinary Shares
Through Spouse6,930$67.72$469K0.1%Form 4, Nov 4, 2026

Share counts are the amounts Pablo G. Legorreta reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
513Severin Hacker
Chief Tech Officer, Co-Founder, Duolingo. Pittsburgh, PA
$454M−$33.2M (−6.81%)
514Richard T. Burke
Director, UnitedHealth Group. Minnetonka, MN
$454M−$26.7M (−5.55%)
515William H. Milmoe
Insider, Celsius Holdings. Delray Beach, FL
$453M−$29.9M (−6.20%)
516Pablo G. Legorreta
CEO, Chairman of the Board, Royalty Pharma. New York, NY
$448M−$2.6M (−0.57%)
517Yoshiyuki Aikawa
Chairman and CEO, SBC Medical Group Holdings. Irvine, CA
$446M−$53.4M (−10.69%)
518Raul Marcelo Claure
Director, T-Mobile US. Bellevue, WA
$445M−$4.1M (−0.91%)
519Keith Manchester
Director, Roivant Sciences
$445M+$2.6M (+0.59%)

Other Royalty Pharma insiders

All RPRX insiders

Questions

How much stock does Pablo G. Legorreta own?

Pablo G. Legorreta holds $448,150,458 in listed stock based on SEC filings and current prices, mostly Royalty Pharma (RPRX). That ranks 516th on the Stock Rich List.

Is this Pablo G. Legorreta's net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.